Morgan Stanley analyst issues EQUAL-WEIGHT recommendation for XP on April 22, 2024 06:18PM ET. XP was trading at $21.11 at issue of the analyst recommendation.The overall analyst consensus : BUY.Current...
Wells Fargo analyst issues EQUAL-WEIGHT recommendation for TSLA on April 22, 2024 06:32PM ET. The previous analyst recommendation was Underweight.TSLA was trading at $142.05 at issue of the analyst recommendation.The...
Wells Fargo analyst issues OVERWEIGHT recommendation for DIS on April 23, 2024 05:07AM ET. The previous analyst recommendation was Overweight.DIS was trading at $111.99 at issue of the analyst recommendation.The...
Wells Fargo analyst issues EQUAL-WEIGHT recommendation for VZ on April 23, 2024 05:08AM ET. The previous analyst recommendation was Equal-Weight.VZ was trading at $38.6 at issue of the analyst recommendation.The...
Morgan Stanley analyst issues OVERWEIGHT recommendation for AAPL on April 22, 2024 01:33AM ET. The previous analyst recommendation was Overweight.AAPL was trading at $165 at issue of the analyst recommendation.The...
Piper Sandler analyst issues OVERWEIGHT recommendation for MSFT on April 22, 2024 04:41AM ET. The previous analyst recommendation was Overweight.MSFT was trading at $399.12 at issue of the analyst recommendation.The...
Jefferies analyst issues BUY recommendation for CRM on April 21, 2024 05:30PM ET. The previous analyst recommendation was Buy.CRM was trading at $270.37 at issue of the analyst recommendation.The overall...
Barclays analyst issues EQUAL-WEIGHT recommendation for MT on April 19, 2024 03:01PM ET. The previous analyst recommendation was Equal-Weight.MT was trading at $25.31 at issue of the analyst recommendation.The overall...
Goldman Sachs analyst issues BUY recommendation for TSM on April 19, 2024 12:31PM ET. The previous analyst recommendation was Buy.TSM was trading at $127.75 at issue of the analyst recommendation.The...
National Bank analyst issues OUTPERFORM recommendation for CVE on April 19, 2024 01:02PM ET. The previous analyst recommendation was Outperform.CVE was trading at $21 at issue of the analyst recommendation.The...
